Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 96, Issue 2, 1997, Pages 123-128

  Bernardino, Jacqueline ^a   Bourgeois, Claire A ^a   Muleris, Martine ^a   Dutrillaux, Anne Marie ^a   Malfoy, Bernard ^a   Dutrillaux, Bernard ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 1; CHROMOSOME 10Q; CHROMOSOME 14Q; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME ANALYSIS; CHROMOSOME PAINTING; CHROMOSOME R BAND; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA HYBRIDIZATION; GENE AMPLIFICATION; GENOME; HUMAN; HUMAN CELL; KARYOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, NEOPLASM; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS; SEQUENCE DELETION; TUMOR CELLS, CULTURED;

EID: 0030791463     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00258-0     Document Type: Article

References (33)

1. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, 2nd ed., Eisevier Publishing Co., New York.
2. Dutrillaux B: (1995): Pathways of chromosome alteration in human epithelial cancers. Adv Cancer Res 67:59-81.
3. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM (1995): Molecular genetics and chromosomal alterations in prostate cancer. Cancer Suppl 75:2004-2012.
4. Gibas Z, Pontes JE, Sandberg AA (1985): Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet 16:301-304.
5. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990): Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
6. Brothman AR. Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF (1991): Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84.
7. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F (1992): Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 4:16-24.
8. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR (1992): Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genet Cytogenet 61:165-173.
9. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993): Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99.
10. Aly MS, Dal Gin P, Van de Voorde W, van Poppel H, Ameye F, Baert L, Van den Berghe H (1994): Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosom Cancer 9:227-233.
11. Micale MA, Sanford JS, Powell IJ, Sakr WA. Wolman SR (1993): Defining the extent and nature of Cytogenetic events in prostatic adenocarcinoma: Paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 69:7-12.
12. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Löhrs U (1994): Interphase Cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 54:4472-4480.
13. Brothman AR. Watson MJ, Zhu XL, Williams BJ, Rohr LR (1994): Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 75:40-44.
14. Henke RP, Krüger E, Ayhan N, Hübner D, Hammerer P (1994): Frequency and distribution of numerical chromosomal aberrations in prostate cancer. Hum Pathol 25:476-484.
15. Alers JC, Krijtenburg PJ, Vissers KJ, Bosnian FT, Van der Kwast TH, Van Dekken H (1995): Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosom Cancer 12:241-250.
16. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990): Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
17. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991): Deletion maping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
18. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB (1993): Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
19. Phillips SMA, Morton DG, Lee SJ, Wallace DMA, Neoptelemos JP (1994): Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73:390-395.
20. Brewster SF, Browne S, Brown KW (1994): Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151:1073-1077.
21. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ (1994): Loss of heterozygosity in human primary prostate carcinomas: A possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373.
22. Visakorpi T, Kallioniemi AH, Syvänen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
23. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978): Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 21:274-281.
24. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979): Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23.
25. Gibas Z, Becher R, Kawinski E, Horoszewicz J, Sandberg AA (1984): A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet Cytogenet 11:399-404.
26. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994): Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
27. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B (1994): Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosom Cancer 10:160-170.
28. Dutrillaux B, Couturier J (1981): La Pratique de l'Analyse Chromosomique, Masson, Paris.
29. Massenkeil G, Oberhuber H, Hailemariam S, Sulser T, Diener PA, Bannwart F, Schäfer R, Schwarte-Walhoff I (1994): P53 mutations and loss of heterozygosity on chromosome 8p, 16q, 17p, and 18q are confined to advanced prostate cancer. Anticancer Res 14:2789-2794.
30. Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, BocconGibod L, Le Duc A, Roue≤ssé J, Lidereau R (1994): Genetic alterations in localized prostate cancer: Identification of a common region of deletiona on chromosome arm 18q. Genes Chromosom Cancer 11:119-125.
31. Trapman J, Sleddens HFBM, van der Veiden MM, Dinjens WNM, Konig JJ, Schroder FH, Faber PW, Bosnian FT (1994): Loss of heterozygosity of chromosome 8 microsatellite loci implicates a condidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064.
32. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J (1995): Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1,2 Mb region of 8p22-p21.3. Genes Chromosom Cancer 13:168-174.
33. Gao X, Zacharek A, Salkowki A, Grignon DJ, Sakr W, Porter AT, Honn KV (1995): Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55:1002-1005.